<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04705740</url>
  </required_header>
  <id_info>
    <org_study_id>NER20</org_study_id>
    <nct_id>NCT04705740</nct_id>
  </id_info>
  <brief_title>Influence of the Endoscopists and Endoscopic Retrograde CholangioPanceratography</brief_title>
  <official_title>Influence of the Endoscopist Case Volumen on Endoscopic Retrograde CholangioPanceratography Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion Miguel Servet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Complejo Hospitalario de Navarra</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion Miguel Servet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective analysis on a prospective database that analyzes the influence of the number of&#xD;
      endoscopists on the Endoscopic Retrograde CholangioPanceratography result.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The number of Endoscopic Retrograde CholangioPanceratographys (ERCP) performed annually by an&#xD;
      endoscopist has been shown to influence the outcomes of the procedure, especially on the&#xD;
      papillary cannulation rate and the adverse effects rate. The number of ERCPs performed&#xD;
      annually by each endoscopist is directly related to the number of endoscopists who perform&#xD;
      this procedure, since the total number of ERCPs performed annually at each center is usually&#xD;
      constant.&#xD;
&#xD;
      The hypothesis of this study is that the number of endoscopists who perform ERCP in a&#xD;
      hospital influences the results of the procedure, so that the fewer the number of&#xD;
      endoscopists the better the results.&#xD;
&#xD;
      To evaluate this hypothesis, the investigators have designed a retrospective study analyzing&#xD;
      data from a prospectively filled database, which includes all ERCPs performed in our center&#xD;
      from September 2013 to June 2020. For organizative reasons unrelated to the endoscopy unit,&#xD;
      in the center it has beed progressively reduced the number of endoscopists who perform ERCP,&#xD;
      starting from 5 endoscopists at the beginning of the study to 3 endoscopists at the end of&#xD;
      the study inclusion period. In fact, three different periods of similar duration can be&#xD;
      distinguished: September 2013 to August 2015 (5 endoscopists), September 2015 to December&#xD;
      2017 (4 endoscopists) and January 2018 to June 2020 (3 endoscopists).&#xD;
&#xD;
      The outcomes obtained with ERCP in these three periods will be analyzed and compared,&#xD;
      assessing the cannulation rate and the adverse effects rate as the main comparison&#xD;
      parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Actual">October 31, 2020</completion_date>
  <primary_completion_date type="Actual">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Papillary cannulation</measure>
    <time_frame>During the procedure</time_frame>
    <description>Rate of papillary cannulation.Success in achieving transpapillary access to the bile duct.It has to be confirmed fluoroscopically</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>Up to 1 month after intervention</time_frame>
    <description>Rate of adverse effect assessed by the ASGE classification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Individual adverse effects</measure>
    <time_frame>Up to 1 month after intervention</time_frame>
    <description>Rate of individual adverse effect during the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complexity level of ERCP</measure>
    <time_frame>During the ERCP procedure</time_frame>
    <description>Complexity level of ERCP according to ASGE classification of complexity of the endoscopic procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Therapeutics performed with ERCP</measure>
    <time_frame>During the ERCP procedure</time_frame>
    <description>Techniques used during ERCP</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">2561</enrollment>
  <condition>Biliary Disease</condition>
  <condition>Pancreatic Diseases</condition>
  <arm_group>
    <arm_group_label>September 2013 to August 2015</arm_group_label>
    <description>5 endoscopists</description>
  </arm_group>
  <arm_group>
    <arm_group_label>September 2015 to December 2017</arm_group_label>
    <description>4 endoscopists</description>
  </arm_group>
  <arm_group>
    <arm_group_label>January 2018 to June 2020</arm_group_label>
    <description>3 endoscopists</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ERCP</intervention_name>
    <description>ERCPs performed annually by an endoscopist</description>
    <arm_group_label>January 2018 to June 2020</arm_group_label>
    <arm_group_label>September 2013 to August 2015</arm_group_label>
    <arm_group_label>September 2015 to December 2017</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 years of age, undergoing ERCP by the staff allocated in the endoscopy&#xD;
        unit.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients undergoing ERCP with written informed consent given&#xD;
&#xD;
          -  Staff allocated in the endoscopy unit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Rejection to participate in the study&#xD;
&#xD;
          -  ERCP procedures performed by fellows in training&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan J Vila, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario de Navarra</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>January 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2021</study_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ERCP</keyword>
  <keyword>endoscopy</keyword>
  <keyword>gastrointestinal</keyword>
  <keyword>choledocholithiasis</keyword>
  <keyword>Endoscopic Retrograde CholangioPanceratography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Diseases</mesh_term>
    <mesh_term>Gallbladder Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

